A clinical observation of ciprofol and propofol on cerebral functional state index and hemodynamic imaging during induction period of general anaesthesia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055635

Enrollment

Unknown

Registered

2022-01-15

Start date

2022-01-14

Completion date

Unknown

Last updated

2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective surgery

Interventions

Group 1 :Intravenous titration of Ciprofo 0.4 mg/kg

Group 2:Intravenous titration of Propofo 2.0 mg/kg

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years; 2. The ASA classification is I-III level; 3. Elective patients undergoing general anesthesia surgery; 4. Respondents agreed to participate in the study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to cyclopofol, propofol injection components and other anesthetics; 2. Patients with neurological symptoms such as cerebrovascular disease, previous history of cerebral infarction and epilepsy; 3. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Wavelet index;	—

Secondary

Measure	Time frame
Cortical excitability index;Subcortical excitability index;Brain energy;Left and right side index;Pain index;Mean arterial pressure;Heart rate;	—

Countries

China

Contacts

Public ContactShi yongchang

The Fourth Hospital of Hebei Medical University

574039430@qq.com+86 15930195575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026